1. Ageing populations: the challenges ahead;Christensen;Lancet,2009
2. Differential prognostic impact of comorbidity;Read;J Clin Oncol,2004
3. Time trends and local variation in primary treatment of localized prostate cancer;Cooperberg;J Clin Oncol,2010
4. Deutsche Gesellschaft für Urologie e. V. Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. Version 2.0–1. Aktualisierung, 2011. [Interdisciplinary guideline of S3 quality for early detection, diagnosis and treatment of the different stages of prostate cancer. Version 2.0—1st update 2011]. 〈http://www.urologenportal.de/fileadmin/MDB/PDF/S3_LL_PCAS3_PCa_Aktualisierung_2011_110912f.pdf〉; [accessed 21.09.13] [in German].
5. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, Mason MD,et al. EAU guidelines on prostate cancer. Update 2013. 〈http://www.uroweb.org/gls/pdf/08%20Prostate%20Cancer_LR%20March%2013th%202012.pdf〉; [accessed 21.09.13].